Toggle navigation
Home
Search
Services
Blog
Contact
About
Lung Malignancies After Breast Cancer/Hodgkins Disease
Adami, H.
Uppsala University, Uppsala, Sweden
Search 93 grants from H. Adami
Search grants from Uppsala University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mechanisms of cKit+ Cardiac Stem Cell-Mediated Repair in Ischemic Cardiomyopathy
Androgen Receptor and SRY/SOX Interaction in Prostate
Function of Transcription Factor Iia in Vivo
Oxygenase Enzyme Mechanism
Isolation of Ristocetin - Von Willebrand Factor
Recently added grants:
Project 1: Molecular Profiling of the Immune Response in Lyme Disease
Core D: Clinical Recruitment
Project 2: Molecular Signatures of West Nile virus susceptibility
Project 3: Effects of Age on Cellular, Transcriptomic and Biochemical Influenza Signatures
Wake Forest Translational Alcohol Research Center (WF-TARC)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Epidemiology And Genetics (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CP061121-000
Application #
2305384
Study Section
Project Start
1996-03-13
Project End
1998-03-12
Budget Start
1996-03-13
Budget End
1997-03-12
Support Year
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Uppsala University
Department
Type
DUNS #
City
Uppsala
State
Country
Sweden
Zip Code
SE-75-1 05
Related projects
NIH 1998
N01 CP
Lung Malignancies After Breast Cancer/Hodgkins Disease
Adami, Hans-Olov / Uppsala University
NIH 1997
N01 CP
Lung Malignancies After Breast Cancer/Hodgkins Disease
Adami, Hans-Olov / Uppsala University
NIH 1996
N01 CP
Lung Malignancies After Breast Cancer/Hodgkins Disease
Adami, H. / Uppsala University
Publications
Travis, Lois B; Hill, Deirdre A; Dores, Graca M et al.
(2003)
Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.
JAMA 290:465-75
Comments
Be the first to comment on this grant